Literature DB >> 11722437

Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis.

K L Mori1, M Egashira, K Oshimi.   

Abstract

In the normal developmental pathway of natural killer (NK) cells, pre-NK cells express CD161, immature NK cells express CD161 and CD56, and mature NK cells express CD161, CD56 and CD94. To identify the normal counterpart of NK cells from which neoplastic cells originate, surface antigens were analysed. Blastic NK-cell lymphoma/leukaemia lacked CD94 and CD161 but had CD56. Aggressive NK-cell leukaemia/lymphoma and nasal NK-cell lymphoma, although morphologically immature, expressed both CD56 and CD94 and strong NK activity. Cells from chronic NK lymphocytosis expressed CD56 and CD94.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722437     DOI: 10.1046/j.1365-2141.2001.03038.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Molecular mechanisms influencing NK cell development: implications for NK cell malignancies.

Authors:  Sally A Mujaj; Michelle M Spanevello; Maher K Gandhi; Jamie P Nourse
Journal:  Am J Blood Res       Date:  2011-05-22

Review 2.  NK cell lymphoma.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma.

Authors:  Yoonjung Kim; Mi Seon Kang; Chan Whan Kim; Rohyun Sung; Young H Ko
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 4.  Leukemia and lymphoma of natural killer lineage cells.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

5.  Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.

Authors:  Margarida Lima; Julia Almeida; Andrés García Montero; Maria dos Anjos Teixeira; Maria Luís Queirós; Ana Helena Santos; Ana Balanzategui; Alexandra Estevinho; Maria del Cármen Algueró; Paloma Barcena; Sónia Fonseca; Maria Luís Amorim; José Manuel Cabeda; Luciana Pinho; Marcos Gonzalez; Jesus San Miguel; Benvindo Justiça; Alberto Orfão
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 6.  Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.

Authors:  Margarida Lima
Journal:  Orphanet J Rare Dis       Date:  2013-07-01       Impact factor: 4.123

Review 7.  Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.

Authors:  Kazuo Oshimi
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

8.  Large granular lymphocyte leukemia and natural killer cell leukemia/lymphomas.

Authors:  Lubomir Sokol; Thomas P Loughran
Journal:  Curr Treat Options Oncol       Date:  2003-08

9.  Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.

Authors:  Paloma Bárcena; María Jara-Acevedo; María Dolores Tabernero; Antonio López; María Luz Sánchez; Andrés C García-Montero; Noemí Muñoz-García; María Belén Vidriales; Artur Paiva; Quentin Lecrevisse; Margarida Lima; Anton W Langerak; Sebastian Böttcher; Jacques J M van Dongen; Alberto Orfao; Julia Almeida
Journal:  Oncotarget       Date:  2015-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.